awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q53389706-83242C81-E1F3-4372-B0C4-890CAF72B6FC
Q53389706-83242C81-E1F3-4372-B0C4-890CAF72B6FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53389706-83242C81-E1F3-4372-B0C4-890CAF72B6FC
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
P2860
Q53389706-83242C81-E1F3-4372-B0C4-890CAF72B6FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53389706-83242C81-E1F3-4372-B0C4-890CAF72B6FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96581c10fc211fecfeeee094cf3bf177ed21caca
P2860
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.